Clinical Trial Update: A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex [Phase 1]

View source ↗

Summary

Phase 1 study of BMY-27857 in patients with HIV infections (AIDS and AIDS-related complex); sponsored by NIAID, the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BMY-27857

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED